Related Experiment Video
Updated: Sep 23, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Polymyxin B-Associated Nephrotoxicity and Its Predictors: A Retrospective Study in Carbapenem-Resistant Gram-Negative
Xiao-Li Wu1,2, Wen-Ming Long3, Qiong Lu1
1Department of Pharmacy, The Second Xiangya Hospital, Institute of Clinical Pharmacy, Central South University, Changsha, China.
Abstract:
Polymyxin B (PMB), a kind of polymyxin, was widely used in carbapenem-resistant Gram-negative bacterial (CR-GNB) infections. However, adverse reactions such as nephrotoxicity and neurotoxicity limit its use in clinical practice. The aim of this study was to explore PMB associated with nephrotoxicity and its predictors. Patients who received PMB intravenous drip for more than 72 h were eligible for the study. Characteristics of patients, concomitant nephrotoxic agents, underlying disease, and antimicrobial susceptibility were submitted for descriptive analysis. Univariate analysis and binary logistic regression were used to assess the factors leading to acute kidney injury (AKI). AKI was assessed with serum creatinine variations according to the classification of risk (stage R), injury (stage I), failure (stage F), loss, and end-stage of kidney disease. Among 234 patients with CR-GNB infections who used PMB in our study, 67 (28.63%) patients developed AKI, including 31 (14.25%) patients in stage R, 15 (6.41%) patients in stage I, and 21 (8.97%) patients in stage F. The incident rate of PMB-related nephrotoxicity in patients with normal renal function was 32.82% (43/131). The higher risk factors of AKI include males [odds ratio (OR) = 3.237; 95% confidence interval (95%CI) = 1.426-7.350], digestive system diseases [OR = 2.481 (1.127-5.463)], using furosemide (>20 mg/day) [OR = 2.473 (1.102-5.551)], and baseline serum creatinine [OR = 0.994 (0.990-0.999)]. Nonparametric tests of K-independent samples showed that baseline serum creatinine and the PMB maintenance dose were associated with the severity of nephrotoxicity (both p < 0.05). Male, digestive system diseases, using furosemide (>20 mg/day), and high baseline serum creatinine were the independent risk factors of PMB-associated AKI development. The maintenance dose of PMB may be related to the severity of AKI. These risk factors should be taken into consideration when initiating PMB-based therapy. The serum creatinine value should be closely monitored when using PMB.
Insights
Polymyxin B (PMB) can cause acute kidney injury (AKI) in patients with carbapenem-resistant Gram-negative bacterial infections. Male sex, digestive diseases, furosemide use, and higher baseline serum creatinine are key risk factors for AKI.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Polymyxin B (PMB) is crucial for treating carbapenem-resistant Gram-negative bacterial (CR-GNB) infections.
- Nephrotoxicity and neurotoxicity are significant adverse effects limiting PMB's clinical application.
Purpose of the Study:
- To investigate the incidence of PMB-associated nephrotoxicity.
- To identify predictors of acute kidney injury (AKI) in patients receiving PMB.
Main Methods:
- Retrospective analysis of 234 patients with CR-GNB infections treated with intravenous PMB for over 72 hours.
- Assessment of AKI using serum creatinine variations based on RIFLE criteria.
- Univariate and binary logistic regression analyses to identify risk factors for AKI.
Main Results:
- 67 out of 234 patients (28.63%) developed AKI.
- Independent risk factors for AKI included male sex (OR=3.237), digestive system diseases (OR=2.481), furosemide use >20 mg/day (OR=2.473), and higher baseline serum creatinine (OR=0.994).
- PMB maintenance dose was associated with AKI severity (p < 0.05).
Conclusions:
- Male sex, digestive diseases, furosemide use, and elevated baseline serum creatinine are independent risk factors for PMB-associated AKI.
- The maintenance dose of PMB may influence AKI severity.
- Close serum creatinine monitoring is recommended during PMB therapy.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Urine Studies II: Urine Culture and Sensitivity Test
Drug Elimination by Renal Route: Tubular Secretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention

